REMIGES VENTURES
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
REMIGES VENTURES
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Similar Organizations
Canvas Ventures
Canvas Ventures is an early-stage investment firm that specializes on fintech, healthtech, marketplaces, and data infrastructure.
Converge
Converge is a venture capital firm that specializes in seed, startup, early Series A, and early-stage investments.
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Obvious Ventures
Obvious Ventures is a venture capital firm that invests in the early and growth stages.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-03 | Immunis | Remiges Ventures investment in Series A - Immunis | 10 M USD |
| 2022-06-06 | LUCA Science | Remiges Ventures investment in Series B - LUCA Science | 3.86 B JPY |
| 2022-02-03 | Restore Vision | Remiges Ventures investment in Seed Round - Restore Vision | 295 M JPY |
| 2021-06-23 | Glycomine | Remiges Ventures investment in Series B - Glycomine | 35 M USD |
| 2020-12-10 | Cyrano Therapeutics | Remiges Ventures investment in Series A - Cyrano Therapeutics | 12.8 M USD |
| 2020-09-01 | LUCA Science | Remiges Ventures investment in Series A - LUCA Science | 9.8 M USD |
| 2020-07-09 | Tranquis Therapeutics | Remiges Ventures investment in Series A - Tranquis Therapeutics | 30 M USD |
| 2018-11-02 | OMEICOS Therapeutics | Remiges Ventures investment in Series C - OMEICOS Therapeutics | 17 M EUR |
| 2018-09-20 | ENB Therapeutics | Remiges Ventures investment in Series A - ENB Therapeutics | 8.09 M USD |
| 2018-06-13 | KisoJi Biotechnology | Remiges Ventures investment in Series A - KisoJi Biotechnology | N/A |